Diabetic Retinopathy Screening
With over 30 million Americans living with diabetes in the United States, 15 million of them have some form of retinal disorder.
Diabetic Retinopathy, a retinal disorder, is the #1 leading cause of blindness in the United States, with roughly 3 million Americans about to go blind today. Symptoms may include blurred vision, floaters, spotty vision, and an inability to differentiate colors. With early detection and treatment, Eagles Landing Health can help slow down the progression of the disease or prevent further vision loss.
What is Diabetic Retinopathy?
Diabetic Retinopathy, one of the major complications of type 1 and type 2 diabetes, causes damage to the back of the eye (retina) due to high blood sugar levels. The blood vessels behind the retina begin leaking fluid behind the nerve tissue, which can lead to blurred vision, severe vision loss, or even blindness. The severity is dependent on whether the patient’s blood sugar levels are controlled and treated. The longer someone lives with uncontrolled diabetes, the more risk you are at for developing Diabetic Retinopathy.
Types of Diabetic Retinopathy:
In Early Diabetic Retinopathy, (also known as non-proliferative) damaged blood vessels leak fluid and blood into the retina and begin to weaken. The leakage can cause swelling of the nerve fibers in the retina, and if left untreated, can lead to loss of vision.
In Advanced Diabetic Retinopathy, (also known as proliferative) new, or abnormal blood vessels start to grow within the retina. These new blood vessels may bleed or leak into the clear, jelly-like substance that fills the center of your eye (vitreous). Over time, scar tissue may begin to form due to the growth of the new blood vessels, which can cause the retina to detach from the back of the eye. This can produce flashes of light, spots floating in your vision, or severe vision loss.
Why go to ELH for your Diabetic Retinopathy Screening?
Quick & Easy
One of the most trusted imaging processes that is not invasive. We have skilled and trained technicians and physicians that will assist you.
Easily Targets Problems Areas
We provide detailed images of the various structures of the retina and can show abnormalities that may threaten normal vision.
Early detection for Diabetic Retinopathy can end preventable blindness.
Managing your diabetes through medication, diet, and physical activity is key in treating Diabetic Retinopathy. When in a mild stage, regulated blood sugar levels can typically slow the progression of the disease. It’s important to work with your Endocrinologist to monitor your condition and take any additional steps necessary to help improve your diabetes. Anyone with a long history of diabetes, especially with poorly or uncontrolled blood sugar, should have regular eye exams.
Types of Diabetic Retinopathy:
At your exam, our technicians will place you in a dark room to help naturally dilate your eyes. If they do not dilate on their own, drops will be placed in your eyes to open your pupils, allowing them to get a better look inside of your eye. Once your eyes have dilated, we will look for new or abnormal blood vessels, swelling, blood, or fat leaking into the retina, growth of new blood vessels or scar tissue, bleeding in the vitreous, retinal detachment, and deformities in the optic nerve.
Location Near You
My stay was short, problem was diagnosed, and I have no complaints. All personnel was friendly and cordial. Everyone acted very professional, in the performance of their duty.
Eurskine L. | ELH Patient
Who should have Diabetic Retinopathy Screening?
• Diabetic patients – for diagnosing and monitoring diabetic retinopathy which can lead to loss of vision
• Glaucoma patients – for early detection of even the slightest changes to the optic never that could lead to the gradual loss of peripheral vision.
• Patients with Macular Degeneration – for diagnosing and monitoring age-related macular degeneration (AMD) for prevention in severe vision loss.
• Patients with other Retinal Diseases and Disorders – for aid in the diagnosis, monitoring, and treatment